Zydus Cadila obtains FDA OK for generic TrintellixZydus Cadila's generic Trintellix tablets provide a treatment for depression. Sun Pharma intros sunitinibSun Pharma's sunitinib capsules are available in four dosage strengths. Aurobindo receives FDA green light for generic Sabril Vigabatrin for oral solution has an estimated market size of $262.5 million for the 12 months ended July 2021, according to IQVIA. Breckenridge receives FDA OK for generic Aubagio Aubagio had a market value of roughly $1.9 billion during the 12 months ended July 2021, according to industry sales data. Upsher-Smith intros three new dosage strengths for generic Absorica Upsher-Smith is partnering with Mayne Pharma to expand product access. FDA approves Samsung Bioepis’ Lucentis biosimilar Byooviz, which is the first biosimilar to Lucentis, provides a treatment for several eye diseases and conditions. Zydus Cadila gets FDA blessing for generic Otezla Zydus Cadila’s generic Otezla provides treatment for adults with moderate to severe plaque psoriasis. Hikma to acquire Custopharm Custopharm, a generic sterile injectables company, markets its products through Leucadia Pharmaceuticals. Aurobindo obtains FDA nod for generic Tricor Aurobindo's fenofibrate capsules will be available in dosage strengths of 67 mg, 134 mg and 200 mg. Glenmark gets FDA green light for generic Evoclin Evoclin Foam had a market value of approximately $12 million for the 12 months endedJuly 2021, according to IQVIA. First Previous 112 113 114 115 116 Next Last
